Xencor | XNCR - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
AbbVie USD 1.77B 1.75B 2025-06
Alnylam Pharmaceuticals USD 133.73M 290K 2026-06
Amgen USD 541M 1000K 2026-06
Arrowhead Research USD 140.57M 3.18M 2026-03
AstraZeneca USD 1.55B 44K 2026-06
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cytokinetics USD 124.43M 2.17M 2026-03
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
J&J USD 2.41B 1.35M 2026-03
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
MacroGenics USD 63.56M 241K 2026-03
Merck USD 2.47B 4.93M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 0 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Xencor USD 74.06M 2.19M 2026-03